Cogent Biosciences, Inc.
Clinical trials sponsored by Cogent Biosciences, Inc., explained in plain language.
-
New hope for Tough-to-Treat stomach tumors in major trial
Disease control OngoingThis large, late-stage study is testing whether adding a new drug called CGT9486 to an existing cancer drug (sunitinib) works better than sunitinib alone for people with advanced gastrointestinal stromal tumors (GIST) that have spread or cannot be removed by surgery. The study wi…
Phase: PHASE3 • Sponsor: Cogent Biosciences, Inc. • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
New drug trial targets debilitating mast cell disease symptoms
Symptom relief OngoingThis study is testing whether an investigational drug called bezuclastinib can better control symptoms in people with nonadvanced systemic mastocytosis, a condition where too many mast cells build up in the body. The trial will compare the drug plus standard care against a placeb…
Phase: PHASE2 • Sponsor: Cogent Biosciences, Inc. • Aim: Symptom relief
Last updated Mar 12, 2026 13:50 UTC